中广核技：控股股东向全资子公司增资5亿元

Core Viewpoint - The company Zhongguang Nuclear Technology (000881) announced that its controlling shareholder, Nuclear Technology Company, plans to increase capital by 500 million yuan to its wholly-owned subsidiary, Medical Technology Company, which will enhance its stake in the subsidiary to 44.13% [1] Group 1 - The capital increase will be used for research and development projects related to proton therapy and future operational development of Medical Technology Company [1] - After the capital increase, Zhongguang Nuclear Technology will hold 55.87% of Medical Technology Company, maintaining it as a controlling subsidiary [1] - The capital increase constitutes a related party transaction as Nuclear Technology Company is a wholly-owned subsidiary of China General Nuclear Power Group (003816), the actual controller of Zhongguang Nuclear Technology [1]